JBIO
Jade Biosciences
JBIO
JBIO
64 hedge funds and large institutions have $639M invested in Jade Biosciences in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.03% less ownership
Funds ownership: 2.94% → 2.91% (-0.03%)
Holders
64
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$9.99M | |
| 2 | +$3.24M | |
| 3 | +$2.43M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.33M |
| 5 |
Morgan Stanley
New York
|
+$1.16M |
Top Sellers
| 1 | -$7.92M | |
| 2 | -$6.4M | |
| 3 | -$2.93M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$2.12M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.36M |